“…The mechanism of action has been proposed by blocking N-methyl-D-aspartate receptor [1]. Amantadine (1-aminotricyclo [3,3,1,13,7]decane) and rimantadine (α-methyltricyclo [3,3,1,13,7]decane-1-methylamine) are structurally related derivatives with similar biological properties. Both effectively suppress viral adsorption [2] and are used, in combination with oseltamivir, for prophylaxis Abbreviations: API, active pharmaceutical ingredients; Arg, l-arginine hydrochloride; BP, British Pharmacopoeia; BPM, brompheniramine; CD, cyclodextrin; TR, transfer ratio; USP, The United States Pharmacopeia Conflicts of interest: The authors have declared no conflicts of interest.…”